[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-371302-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-371302-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","hpv-biomarkers-in-oral-and-blood-derived-body-fluids-in-head-and-neck-cancer-patients-research-article","HPV Biomarkers in Oral and Blood‐Derived Body Fluids in Head and Neck Cancer Patients - Research Article","","Oral HPV DNA and circulating tumor (ct) HPV DNA in plasma were evaluated as potential biomarkers for HPV-associated head and neck cancer (HNC). Samples from HNC patients (n=132), including 23 oropharyngeal cancers (OPC), and non-HNC controls (n=10) were analyzed. HPV status used a multiplex bead-based test (E7-MPG) on FFPE tissues, plasma, gargle samples, and oral swabs. HPV DNA was detected in multiple specimen types, with high concordance between paired OPC tissues and plasma or gargles. Gargle samples showed a superior HPV16 detection rate for OPC, and combined oral gargle and plasma testing detected all HPV-positive OPC cases at early cT1.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/hpv-biomarkers-in-oral-and-blood-derived-body-fluids-in-head-and-neck-cancer-patients-research-article/371302/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/hpv-biomarkers-in-oral-and-blood-derived-body-fluids-in-head-and-neck-cancer-patients-research-article/371302.png","ImageObject",300,407,{"name":42,"@type":43},"Ezra","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What biomarkers were assessed in this study for HPV-associated head and neck cancer?","Question",{"text":63,"@type":64},"The study evaluated oral HPV DNA and circulating tumor (ct) HPV DNA in plasma as potential biomarkers for HPV-associated head and neck cancer.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How was HPV status determined across different specimen types?",{"text":68,"@type":64},"HPV status was determined using a multiplex bead-based test (E7-MPG) applied to FFPE tissues, plasma, gargle samples, and oral swabs.",{"name":70,"@type":61,"acceptedAnswer":71},"Which sample type performed best for detecting HPV16-positive oropharyngeal cancer?",{"text":72,"@type":64},"Gargle samples demonstrated a 100% detection rate for HPV16-positive OPC, outperforming plasma detection.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},371302,1790619559,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Journal of  \nMedical Virology  \nRESEARCH ARTICLE   \nHPV Biomarkers in Oral and Blood‐Derived Body Fluids in Head and Neck Cancer Patients  \nLuisa Galati1 | Marta Tagliabue2,3  | Tarik Gheit4 | Rita De Berardinis2  | Fausto Maffini5  | Sandrine McKay‐Chopin4 | Giuseppe De Palma6 | Stefania Vecchio7 | Angelo Virgilio Paradiso6 | Laura Sichero8,9  | Luisa Lina Villa8,10 | Francesco Chu2 | Francesco Bandi2 | Chiara Mossinelli2 | Jacopo Zocchi2 | Giacomo Pietrobon2 | Stefano Filippo Zorzi2 | Enrica Grosso2 | Stefano Riccio2 | Roberto Bruschini2 | Gioacchino Giugliano2 | Giovanni Blandino11 | Maria Lina Tornesello12 |  \nMohssen Ansarin2 | Massimo Tommasino4† | Susanna Chiocca1   \n1Department of Experimental Oncology, IEO, European Institute of Oncology IRCCS, Milan, Italy | 2Division of Otolaryngology and Head and Neck Surgery, IEO, European Institute of Oncology IRCCS, Milan, Italy | 3Department of Biomedical Sciences, University of Sassari, Sassari, Italy | 4International Agency for Research on Cancer (IARC), Lyon, France | 5Department of Surgical Pathology, IEO, European Institute of Oncology IRCCS, Milan, Italy | 6Experimental Oncology and Biobank Management Unit, Institutional BioBank, IRCCS Istituto Tumori Giovanni Paolo II Bari, Bari, Italy | 7IRCCS Ospedale Policlinico San Martino, Genova, Italy | 8Center for Translational Research in Oncology, Instituto do Cancer do Estado de Sao Paulo ICESP, Hospital das Clinicas da Faculdade de Medicina da Universidade de Sao Paulo FMUSP HC, Sao Paulo, Sao Paulo, Brazil | 9Comprehensive Center for Precision Oncology, Universidade de Sao Paulo, Sao Paulo, São Paulo, Brazil | 10Department of Radiology and Oncology, Faculdade de Medicina, Universidade de São Paulo, São Paulo, São Paulo, Brazil | 11Translational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Roma, Italy | 12Molecular Biology and  \nViral Oncology Unit, IRCCS Istituto Nazionale dei Tumori “Fondazione G. Pascale”, Napoli, Italy Correspondence: Tarik Gheit ([gheitt@iarc.who.int](gheitt@iarc.who.int)) | Susanna Chiocca ([susanna.chiocca@ieo.it](susanna.chiocca@ieo.it))  \nReceived: 27 November 2024 | Revised: 23 January 2025 | Accepted: 19 February 2025  \nFunding: We thank the Funders: Italian Ministry of Health with Ricerca Corrente, Reti RCR‐2020‐23670066, and 5 × 1000 funds, Alliance Against Cancer (ACC) Head and neck tumors,(WP 5), Fondazione AIRC per la Ricerca sul Cancro ETS to S. Chiocca (IG 2022 ID 27043) . Luisa Galati was supported by a Fondazione Umberto Veronesi fellowship.  \nKeywords: biomarkers | body fluids | Head and neck squamous cell carcinoma | head neck cancer | HPV | HPV DNA | HPV16 | oropharyngeal cancer | plasma | saliva  \nABSTRACT  \nOral HPV DNA and circulating tumor (ct) HPV DNA in plasma were evaluated as potential biomarkers for HPV‐associated head and neck cancer (HNC) . Samples from HNC patients (n = 132), including 23 oropharyngeal cancers (OPC), and non‐HNC controls (n = 10) were analyzed. HPV status was determined using a multiplex bead‐based test (E7‐MPG) applied to formalin‐ fixed paraffin‐embedded (FFPE) tissues (n = 90), plasma (n = 141), gargle samples (n = 141), and oral swabs (n = 142) . HPV DNA was detected in 25.8% of HNC tissues, 12% of plasma samples, 20.6% of gargles and 7% of oral swabs with HPV16 as the most prevalent genotype. Among OPC cases, HPV16 DNA was found in 71.4% of FFPE samples. High concordance was observed between paired OPC tissues and plasma (91.3%) or gargles (95.2%), with moderate concordance for oral swabs (59.1%) . Gargle samples alone demonstrated a 100% detection rate for HPV16‐positive OPC, regardless of the cT stage, outperforming plasma (86.7%) . Combined oral gargle and plasma analyses detected all HPV‐positive OPC cases (7/7) at the early cT1 stage. These findings highlight the limited involvement of HPV in non‐oropharyngeal HNC compared to OPC, and support gargle and plasma samples as minimally invasive diagnostic tools for detecting HPV","cbCainKbVEXs9fg2","https://ap.wps.com/l/cbCainKbVEXs9fg2","pdf",1144058,13,"English","# Abstract\n# Introduction\n## Head and neck cancers and HPV risk\n## Epidemiology of HPV-associated oropharyngeal cancer\n## Lack of validated screening protocols and HPV status testing methods","[{\"question\":\"What biomarkers were assessed in this study for HPV-associated head and neck cancer?\",\"answer\":\"The study evaluated oral HPV DNA and circulating tumor (ct) HPV DNA in plasma as potential biomarkers for HPV-associated head and neck cancer.\"},{\"question\":\"How was HPV status determined across different specimen types?\",\"answer\":\"HPV status was determined using a multiplex bead-based test (E7-MPG) applied to FFPE tissues, plasma, gargle samples, and oral swabs.\"},{\"question\":\"Which sample type performed best for detecting HPV16-positive oropharyngeal cancer?\",\"answer\":\"Gargle samples demonstrated a 100% detection rate for HPV16-positive OPC, outperforming plasma detection.\"}]","HPV Biomarkers in Oral and Blood‐Derived Body Fluids in Head and Neck Cancer Patients - Research Article | PDF",1790191743,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/374a440e2b3a4d853d0d8c70d626e83c.webp",983,1291,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6f9a534c872c751ba4c112d25c36d01c.webp",982,1290,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/23a58b413aa01216dde6478cca24736a.webp",981,1289,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f9ef6deb9219b660265570d84a9e60ed.webp",980,1287]